0000950142-24-000025.txt : 20240103 0000950142-24-000025.hdr.sgml : 20240103 20240103145932 ACCESSION NUMBER: 0000950142-24-000025 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 EFFECTIVENESS DATE: 20240103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PCA Opportunities Fund 2023, L.P. - Series E (Life Sciences IV) CENTRAL INDEX KEY: 0002006308 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-501436 FILM NUMBER: 24505775 BUSINESS ADDRESS: STREET 1: 71 RIDGEVIEW AVENUE CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: (212) 355-3250 MAIL ADDRESS: STREET 1: 71 RIDGEVIEW AVENUE CITY: GREENWICH STATE: CT ZIP: 06830 D 1 primary_doc.xml X0708 D LIVE 0002006308 PCA Opportunities Fund 2023, L.P. - Series E (Life Sciences IV) C/O PRECISION CAPITAL 2023 GP, L.P. 71 RIDGEVIEW AVENUE GREENWICH CT CONNECTICUT 06830 212-355-3250 DELAWARE None None Limited Partnership true 2023 Todd Kesselman 71 Ridgeview Avenue Greenwich CT CONNECTICUT 06830 Executive Officer Manager of the Issuer's Ultimate General Partner Gina LaVersa 71 Ridgeview Avenue Greenwich CT CONNECTICUT 06830 Executive Officer Manager of the Issuer's Ultimate General Partner - Precision Capital 2023 GP, L.P. 71 Ridgeview Avenue Greenwich CT CONNECTICUT 06830 Promoter General Partner of the Issuer Pooled Investment Fund Private Equity Fund false Decline to Disclose 06b 3C 3C.7 false true false true true false 1 Indefinite 0 Indefinite The first sale has yet to occur. false 0 0 0 0 Customary management fees will be paid to Precision Capital Advisors, LLC, an entity controlled by certain individuals listed in Item 3 above. false PCA Opportunities Fund 2023, L.P. - Series E (Life Sciences IV) /s/ Gina LaVersa Gina LaVersa Managing Member of the Issuer's Ultimate General Partner 2024-01-03